anmelden
GSK Aktie
22,14
EUR
+0,33
EUR
+1,51
%
22,23
EUR
+0,47
EUR
+2,16
%
GSK jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 86,4 Mrd. EUR
KGV 12,93 Div. Rendite 3,62%WKN A3DMB5
ISIN GB00BN7SWP63
Symbol GLAXF
AI Analyse
Werbung
GSK Aktie Analyse
| 01.07.22 | GSK Underperform | Credit Suisse Group | |
| 29.06.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.06.22 | GSK Buy | Jefferies & Company Inc. | |
| 13.06.22 | GSK Hold | Deutsche Bank AG | |
| 10.06.22 | GSK Neutral | UBS AG | |
| 10.06.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.06.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 06.06.22 | GSK Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 01.06.22 | GSK Hold | Deutsche Bank AG | |
| 01.06.22 | GSK Equal Weight | Barclays Capital | |
| 31.05.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 31.05.22 | GSK Neutral | UBS AG | |
| 27.05.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.05.22 | GSK Buy | Jefferies & Company Inc. | |
| 19.05.22 | GSK Hold | Deutsche Bank AG | |
| 13.05.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 10.05.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.04.22 | GSK Equal Weight | Barclays Capital | |
| 28.04.22 | GSK Hold | Deutsche Bank AG | |
| 28.04.22 | GSK Underperform | Credit Suisse Group | |
| 28.04.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 28.04.22 | GSK Neutral | UBS AG | |
| 27.04.22 | GSK Buy | Jefferies & Company Inc. | |
| 22.04.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 22.04.22 | GSK Hold | Deutsche Bank AG | |
| 19.04.22 | GSK Buy | Jefferies & Company Inc. | |
| 13.04.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 11.04.22 | GSK Neutral | UBS AG | |
| 05.04.22 | GSK Buy | Jefferies & Company Inc. | |
| 01.04.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 08.03.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.03.22 | GSK Neutral | UBS AG | |
| 28.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.02.22 | GSK Neutral | UBS AG | |
| 21.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.02.22 | GSK Neutral | UBS AG | |
| 18.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 10.02.22 | GSK Underperform | Credit Suisse Group | |
| 09.02.22 | GSK Neutral | UBS AG | |
| 09.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.02.22 | GSK Buy | Jefferies & Company Inc. | |
| 02.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 02.02.22 | GSK Buy | Jefferies & Company Inc. | |
| 28.01.22 | GSK Equal Weight | Barclays Capital | |
| 27.01.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 17.01.22 | GSK Equal Weight | Barclays Capital | |
| 17.01.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 17.01.22 | GSK Neutral | UBS AG | |
| 17.01.22 | GSK Underperform | Credit Suisse Group | |
Werbung
Werbung
